INTERPACE BIOSCIENCES, INC. Quarterly Selling and Marketing Expense in USD from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Interpace Biosciences, Inc. quarterly/annual Selling and Marketing Expense history and growth rate from Q1 2014 to Q2 2024.
  • Interpace Biosciences, Inc. Selling and Marketing Expense for the quarter ending June 30, 2024 was $2.89M, a 10.8% increase year-over-year.
  • Interpace Biosciences, Inc. Selling and Marketing Expense for the twelve months ending June 30, 2024 was $11M, a 17.9% increase year-over-year.
  • Interpace Biosciences, Inc. annual Selling and Marketing Expense for 2023 was $10.2M, a 12.1% increase from 2022.
  • Interpace Biosciences, Inc. annual Selling and Marketing Expense for 2022 was $9.13M, a 0.57% decline from 2021.
  • Interpace Biosciences, Inc. annual Selling and Marketing Expense for 2021 was $9.18M, a 0.83% decline from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $11M $2.89M +$282K +10.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $10.7M $2.82M +$479K +20.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $10.2M $2.79M +$650K +30.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $9.58M $2.5M +$262K +11.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $9.32M $2.61M +$54K +2.12% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $9.27M $2.34M +$142K +6.46% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $9.13M $2.14M +$332K +18.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $8.79M $2.24M -$8K -0.36% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $8.8M $2.55M -$225K -8.11% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $9.03M $2.2M -$151K -6.42% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $9.18M $1.81M -$672K -27.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-27
Q3 2021 $9.85M $2.24M -$455K -16.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $10.3M $2.78M +$1.18M +73.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $9.12M $2.35M -$130K -5.24% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $9.25M $2.48M -$511K -17.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $9.77M $2.7M -$58K -2.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $9.82M $1.6M -$1.36M -46.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $11.2M $2.48M +$70K +2.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 $11.1M $2.99M +$702K +30.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-01
Q3 2019 $10.4M $2.76M +$709K +34.6% Jul 1, 2019 Sep 30, 2019 10-Q 2021-01-20
Q2 2019 $9.71M $2.96M +$864K +41.2% Apr 1, 2019 Jun 30, 2019 10-Q/A 2021-01-19
Q1 2019 $8.84M $2.41M +$420K +21.1% Jan 1, 2019 Mar 31, 2019 10-Q/A 2021-01-19
Q4 2018 $8.42M $2.29M +$227K +11% Oct 1, 2018 Dec 31, 2018 10-K/A 2021-01-19
Q3 2018 $8.19M $2.05M +$232K +12.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $7.96M $2.1M +$540K +34.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 $7.42M $1.99M +$855K +75.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 $6.57M $2.06M +$749K +57.1% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-21
Q3 2017 $5.82M $1.82M +$534K +41.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $5.28M $1.56M +$233K +17.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $5.05M $1.14M -$411K -26.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $5.46M $1.31M -$660K -33.5% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-23
Q3 2016 $6.12M $1.28M -$1.59M -55.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 $7.72M $1.32M -$1.96M -59.8% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 $9.68M $1.55M -$679K -30.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 $10.4M $1.97M +$1.37M +226% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 $8.99M $2.88M +$2.88M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-17
Q2 2015 $6.12M $3.29M +$3.29M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 $2.83M $2.23M +$2.23M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 $604K $604K Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 $0 Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $0 Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 $0 Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.